03/31/2010 - Pfizer, the world’s largest drug maker, said Wednesday that it paid about $20 million to 4,500 doctors and other medical professionals for consulting and speaking on its behalf in the last six months of 2009, its first public accounting of payments to the people who decide which drugs to recommend.
* * *
Pfizer is the fourth major drug company to make such disclosures, following Eli Lilly, Merck and GlaxoSmithKline. All four Web sites are searchable by the names of doctors or organizations, but all are set up in ways that make it difficult to download and analyze the entire database.
“All of them are welcome, but none of them is a replacement for a single national database,” said Allan Coukell, director of the Pew Prescription Project, an initiative of The Pew Charitable Trusts.
Read the full article Pfizer Gives Details on Payments to Doctors on the New York Times' Web site.